Exarmed Pharma Private Limited
About Exarmed Pharma Private Limited
Data last updated:
Exarmed Pharma Private Limited was a private limited company based in Gujvail, Telangana, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 January 2019.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2019PTC129565. Its GSTIN is 36AAFCE3259H1ZL (Telangana).
The company had an authorised share capital of ₹13.5 Cr and a paid-up capital of ₹13.5 Cr. It was led by directors including Bala Murali Krishna Thippabhotla and Jahnavi Puchakayala.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at A Biotech Park, Survey 321 Plot No. 55/A Biotech Park Phase III Tsiic, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹23.29 Lakh, a growth of 109% compared to the previous year. For the same year it recorded a net profit of ₹47.26 Lakh (net margin 202.9%) and EBITDA of ₹3.62 Lakh (EBITDA margin 15.5%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
Company details
Contact details
Exarmed Pharma Private Limited's registered office is in Gujvail, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSurvey 321 Plot No. 55/A Biotech Park Phase III Tsiic, Karakapatla Village Markook Mandal Siddipet District Telangana 502281, Gujvail, Telangana, India – 502281
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Exarmed Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Exarmed Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Exarmed Pharma Private Limited, buy the company report.
Financials of Exarmed Pharma Private Limited
FY 2023 filings availableExarmed Pharma Private Limited reported revenue of ₹23.29 Lakh (up 109% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over three years, including 109% growth in the latest year. EBITDA rose 359% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹23.29 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.62 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.5% | ||||
| Net Profit Margin | 202.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exarmed Pharma Private Limited, buy the company report.
Board of directors and KMP of Exarmed Pharma Private Limited
Exarmed Pharma Private Limited currently reports 3 directors and 1 key managerial person. 1 former director has served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bala Murali Krishna Thippabhotla | Director | 01 Jul 2019 | 7 Years 3 Months | As last reported |
| Jahnavi Puchakayala | Director | 08 Jan 2019 | 7 Years 9 Months | As last reported |
| Vajrala Bhulakshmi Also directs: Exarmed Pharma LLP | Director | 08 Jan 2019 | 7 Years 9 Months | As last reported |
| Madhusudhan Reddy | Company Secretary | 01 Nov 2022 | 3 Years 11 Months | As last reported |
Peer comparison
Exarmed Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| I. C. Medicare Private Limited | ₹23.46 Lakh (FY 2019) | 22.0% | New Delhi, Delhi, India | |||
| Exarmed Pharma Private Limitedthis company | ₹23.29 Lakh (FY 2023) | ₹47.26 Lakh | 202.9% | 109.0% | Gujvail, Telangana, India | |
| Nourish Pharmaceutical Private Limited | ₹23.16 Lakh (FY 2024) | -81.0% | Gujarat, India | |||
| Moxie Pharmaceutical Private Limited | ₹23.15 Lakh (FY 2023) | -62.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Exarmed Pharma Private Limited, buy the company report.
Auditor
Exarmed Pharma Private Limited is audited by NSVR Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NSVR Associates LLP | FY 2023 | 008801S |
Shareholding
The shareholding of Exarmed Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Exarmed Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Exarmed Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exarmed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Exarmed Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
Exarmed Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCE3259H1ZL | Telangana | Active | 17 Sep 2019 |
To see the full GST registrations and return filing status of Exarmed Pharma Private Limited, buy the company report.
Recent activity
Exarmed Pharma Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Madhusudhan Reddy was appointed as Company Secretary on 01 Nov 2022.
Frequently asked questions
Exarmed Pharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Exarmed Pharma was a private limited company based in Gujvail, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 08 January 2019 and is registered under CIN U24110TG2019PTC129565. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Exarmed Pharma is U24110TG2019PTC129565. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exarmed Pharma had 4 directors and KMP:
- Bala Murali Krishna Thippabhotla - Director
- Jahnavi Puchakayala - Director
- Vajrala Bhulakshmi - Director
- Madhusudhan Reddy - Company Secretary
Exarmed Pharma was incorporated on 08 January 2019. It is registered with the Registrar of Companies, Hyderabad.
The registered office of Exarmed Pharma is at Survey 321 Plot No. 55A Biotech Park Phase III Tsiic, Karakapatla Village Markook Mandal Siddipet District Telangana 502281, Gujvail, Telangana, India – 502281.
The latest financial statements of Exarmed Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Exarmed Pharma is 36AAFCE3259H1ZL, registered in Telangana.
Exarmed Pharma operated in the pharma industry, in the drug formulation and development segment.
The peers of Exarmed Pharma by revenue are I. C. Medicare Private Limited, Nourish Pharmaceutical Private Limited, Moxie Pharmaceutical Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Madhusudhan Reddy was appointed as Company Secretary on 01 Nov 2022. Bala Murali Krishna Thippabhotla ceased to be Additional Director on 31 Dec 2020. Bala Murali Krishna Thippabhotla was appointed as Director on 01 Jul 2019. Exarmed Pharma has 5 board changes on record in total.